ZA87216B - A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof - Google Patents
A pharmaceutical composition with sustained release of the active component and a process for the preparation thereofInfo
- Publication number
- ZA87216B ZA87216B ZA87216A ZA87216A ZA87216B ZA 87216 B ZA87216 B ZA 87216B ZA 87216 A ZA87216 A ZA 87216A ZA 87216 A ZA87216 A ZA 87216A ZA 87216 B ZA87216 B ZA 87216B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- pharmaceutical composition
- active component
- sustained release
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8600050A NL8600050A (nl) | 1986-01-13 | 1986-01-13 | Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA87216B true ZA87216B (en) | 1987-08-26 |
Family
ID=19847407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA87216A ZA87216B (en) | 1986-01-13 | 1987-01-13 | A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0230332A1 (da) |
JP (1) | JPS62209025A (da) |
DK (1) | DK16187A (da) |
FI (1) | FI870092A (da) |
IL (1) | IL81232A0 (da) |
NL (1) | NL8600050A (da) |
NO (1) | NO870104L (da) |
ZA (1) | ZA87216B (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300111B1 (en) * | 1987-07-22 | 1991-10-16 | Farvalsa AG | A moisture stable solid valproic acid formulation and a method of preparing the same |
JPH023609A (ja) * | 1988-06-21 | 1990-01-09 | Fujimoto Seiyaku Kk | 塩酸ニカルジピンを活性成分とする持効性製剤 |
GR1000466B (el) * | 1989-01-28 | 1992-07-30 | Sandoz Ag | Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης. |
GB2230440B (en) * | 1989-02-09 | 1993-05-19 | Sandoz Ltd | Novel cyclosporin galenic forms |
US5268181A (en) * | 1989-04-13 | 1993-12-07 | Upsher-Smith Laboratories, Inc. | Method of using niacin to control nocturnal cholesterol synthesis |
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
DE19840152A1 (de) * | 1998-09-03 | 2000-03-09 | Dresden Arzneimittel | Calciumvalproat enthaltende pharmazeutische Zusammensetzungen mit retardierter Wirkstoff-Freisetzung, Verfahren zu deren Herstellung und deren Verwendung |
AU1031500A (en) * | 1998-11-03 | 2000-05-22 | Dandy A/S | Sucrose fatty acid esters for use as increased release of active ingredients |
US20030027786A1 (en) | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
KR20030095600A (ko) * | 2002-06-12 | 2003-12-24 | 환인제약 주식회사 | 펠로디핀을 포함하는 제어방출형 조성물 및 그 제조방법 |
AU2004264958B2 (en) | 2003-08-13 | 2010-04-15 | Biocon, Ltd | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
JP7469550B1 (ja) * | 2022-10-21 | 2024-04-16 | 第一工業製薬株式会社 | 固体組成物及びその製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1080265B (de) * | 1958-09-30 | 1960-04-21 | Bayer Ag | Verfahren zur Herstellung von oral anzuwendenden Arzneimittel-zubereitungen mit protrahierter Wirkung aus Wirkstoffen und Schutzstoffen |
FR2518403B1 (fr) * | 1981-12-22 | 1987-01-02 | Dietlin Francois | Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues |
-
1986
- 1986-01-13 NL NL8600050A patent/NL8600050A/nl not_active Application Discontinuation
-
1987
- 1987-01-12 FI FI870092A patent/FI870092A/fi not_active IP Right Cessation
- 1987-01-12 EP EP87200031A patent/EP0230332A1/en not_active Withdrawn
- 1987-01-12 NO NO870104A patent/NO870104L/no unknown
- 1987-01-12 IL IL81232A patent/IL81232A0/xx unknown
- 1987-01-13 JP JP62007403A patent/JPS62209025A/ja active Pending
- 1987-01-13 DK DK016187A patent/DK16187A/da not_active Application Discontinuation
- 1987-01-13 ZA ZA87216A patent/ZA87216B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS62209025A (ja) | 1987-09-14 |
NO870104D0 (no) | 1987-01-12 |
FI870092A (fi) | 1987-07-14 |
NO870104L (no) | 1987-07-14 |
DK16187D0 (da) | 1987-01-13 |
DK16187A (da) | 1987-07-14 |
FI870092A0 (fi) | 1987-01-12 |
EP0230332A1 (en) | 1987-07-29 |
IL81232A0 (en) | 1987-08-31 |
NL8600050A (nl) | 1987-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR243382A1 (es) | Procedimiento para preparar composiciones farmaceuticas para administracion endovenosa. | |
EP0224146A3 (en) | Pharmaceutical preparation for the controlled release of active ingredients | |
HK18796A (en) | New amino acid derivatives processes for the preparation thereof and pharmaceutical composition comprising the same | |
HUT41418A (en) | Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents | |
PT83508A (en) | Process for the preparation of pharmaceutical compositions with controlled release | |
PT84936A (en) | Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same | |
IL95120A0 (en) | Preparation of a pharmaceutical composition in the form of microparticles | |
EP0251459A3 (en) | Controlled release pharmaceutical composition | |
HU893392D0 (en) | Process for the preparation of peptides with t-cell helping activity and pharmaceutical compositions containing them | |
HU896428D0 (en) | Process for the preparation of imidazoles and pharmaceutical compositions thereof | |
HU900221D0 (en) | Fungicid composition comprising acyl-amino-benzamides as active ingredient and process for preparation thereof | |
HU900184D0 (en) | Process for preparation of new imidazol-derivatives and for manufacturing of the pharmaceutical composition containing thereof | |
GB2149413B (en) | Sustained release pharmaceutical tablets and process for the preparation thereof | |
GB2187643B (en) | Method for the preparation of tablets slowly releasing the active principle | |
HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
GB8924286D0 (en) | Pharmaceutical composition and process for preparing the same | |
IL77322A (en) | Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof | |
GB2167746B (en) | A process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it | |
ZA87216B (en) | A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof | |
PT84358A (en) | Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same | |
PT86407A (en) | Process for the preparation of new alkanesulfonanilide derivatives and pharmaceutical compositions comprising the same | |
HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
NZ222116A (en) | 3-propenylcephem derivatives and pharmaceutical compositions; processes for preparation | |
HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient |